Neuraxis, INC cotiza a 6.26 USD y tiene una capitalización bursátil de $79M. En los últimos 12 meses ha facturado $5M con un margen de flujo de caja libre del -181.1%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 8 years of age with functi…
| Periodo | 2026-03 | 2025-11 | 2025-08 | 2025-05 |
|---|---|---|---|---|
| Real | $-0.10 | $-0.24 | $-0.22 | $-0.33 |
| Estimado | $-0.21 | $-0.20 | $-0.19 | $-0.24 |
| Sorpresa | +52.4% | -20.0% | -15.8% | -37.5% |
| Métrica | NRXS | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 84.2% | 57.0% | +27.2% |
| Operating Margin | -219.4% | -38.6% | -180.8% |
| Net Margin | -218.6% | -33.6% | -185.0% |
| FCF Margin | -181.1% | -13.9% | -167.2% |
| ROE | -229.5% | -40.4% | -189.1% |
| ROA | -121.8% | -32.0% | -89.8% |
| Current Ratio | 2.05 | 2.84 | -0.79 |
| Debt / Equity | — | 0.28 | — |